MND1 and cancer: The group of Greenberg and colleagues discovered that the HOP2-MND1 heterodimer functions in cancer cells to promote an alternative lengthening of telomeres (ALT) mechanism in the absence of telomerase activity (Nam Woo Cho et al., 2014).